Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers

Darawan Thapinta; Richard A. Jenkins; David D. Celentano; Sorachai Nitayaphan; Puangmalee Buapunth; Attaporn Triampon; Patricia A. Morgan; Chirasak Khamboonruang; Chanmet Suwanarach; Yupadee Yutabootr; Somsri Ruckphaopunt; Siriporn Suwankiti; Vanida Tubtong; Wipada Cheewawat; John G. McNeil; Rodney A. Michael

doi:10.1097/00042560-199903010-00015

Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers

Darawan Thapinta, Richard A. Jenkins, David D. Celentano, Sorachai Nitayaphan, Puangmalee Buapunth, Attaporn Triampon, Patricia A. Morgan, Chirasak Khamboonruang, Chanmet Suwanarach, Yupadee Yutabootr, Somsri Ruckphaopunt, Siriporn Suwankiti, Vanida Tubtong, Wipada Cheewawat, John G. McNeil, Rodney A. Michael

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

Behavioral and social issues were investigated in phase I/II preventive HIV vaccine trial volunteers in Thailand. These included risk behavior, HIV knowledge, distress, and social experiences associated with trial participation. Data were collected at baseline and at 4- and 8-month follow- up visits. Volunteers reported relatively low levels of risk behaviors at baseline and at the follow-up visits. About one fifth reported overtly negative reactions from family or friends. No problems with discrimination in employment, health care, or insurance were reported. Findings add to the evidence suggesting the feasibility of phase I/II prophylactic HIV vaccine trials with low-risk volunteers in Thailand.

Original language	English (US)
Pages (from-to)	308-314
Number of pages	7
Journal	Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume	20
Issue number	3
DOIs	https://doi.org/10.1097/00042560-199903010-00015
State	Published - Mar 1 1999

Keywords

Developing countries
HIV sexual risk behavior
HIV vaccine trials
Thailand

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Virology

Access to Document

10.1097/00042560-199903010-00015

Cite this

Thapinta, D., Jenkins, R. A., Celentano, D. D., Nitayaphan, S., Buapunth, P., Triampon, A., Morgan, P. A., Khamboonruang, C., Suwanarach, C., Yutabootr, Y., Ruckphaopunt, S., Suwankiti, S., Tubtong, V., Cheewawat, W., McNeil, J. G., & Michael, R. A. (1999). Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(3), 308-314. https://doi.org/10.1097/00042560-199903010-00015

Thapinta, D, Jenkins, RA, Celentano, DD, Nitayaphan, S, Buapunth, P, Triampon, A, Morgan, PA, Khamboonruang, C, Suwanarach, C, Yutabootr, Y, Ruckphaopunt, S, Suwankiti, S, Tubtong, V, Cheewawat, W, McNeil, JG & Michael, RA 1999, 'Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 20, no. 3, pp. 308-314. https://doi.org/10.1097/00042560-199903010-00015

@article{f60d854931d840c1a83f13be2088bad5,

title = "Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers",

abstract = "Behavioral and social issues were investigated in phase I/II preventive HIV vaccine trial volunteers in Thailand. These included risk behavior, HIV knowledge, distress, and social experiences associated with trial participation. Data were collected at baseline and at 4- and 8-month follow- up visits. Volunteers reported relatively low levels of risk behaviors at baseline and at the follow-up visits. About one fifth reported overtly negative reactions from family or friends. No problems with discrimination in employment, health care, or insurance were reported. Findings add to the evidence suggesting the feasibility of phase I/II prophylactic HIV vaccine trials with low-risk volunteers in Thailand.",

keywords = "Developing countries, HIV sexual risk behavior, HIV vaccine trials, Thailand",

author = "Darawan Thapinta and Jenkins, {Richard A.} and Celentano, {David D.} and Sorachai Nitayaphan and Puangmalee Buapunth and Attaporn Triampon and Morgan, {Patricia A.} and Chirasak Khamboonruang and Chanmet Suwanarach and Yupadee Yutabootr and Somsri Ruckphaopunt and Siriporn Suwankiti and Vanida Tubtong and Wipada Cheewawat and McNeil, {John G.} and Michael, {Rodney A.}",

year = "1999",

month = mar,

day = "1",

doi = "10.1097/00042560-199903010-00015",

language = "English (US)",

volume = "20",

pages = "308--314",

journal = "Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",

issn = "1077-9450",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers

AU - Thapinta, Darawan

AU - Jenkins, Richard A.

AU - Celentano, David D.

AU - Nitayaphan, Sorachai

AU - Buapunth, Puangmalee

AU - Triampon, Attaporn

AU - Morgan, Patricia A.

AU - Khamboonruang, Chirasak

AU - Suwanarach, Chanmet

AU - Yutabootr, Yupadee

AU - Ruckphaopunt, Somsri

AU - Suwankiti, Siriporn

AU - Tubtong, Vanida

AU - Cheewawat, Wipada

AU - McNeil, John G.

AU - Michael, Rodney A.

PY - 1999/3/1

Y1 - 1999/3/1

N2 - Behavioral and social issues were investigated in phase I/II preventive HIV vaccine trial volunteers in Thailand. These included risk behavior, HIV knowledge, distress, and social experiences associated with trial participation. Data were collected at baseline and at 4- and 8-month follow- up visits. Volunteers reported relatively low levels of risk behaviors at baseline and at the follow-up visits. About one fifth reported overtly negative reactions from family or friends. No problems with discrimination in employment, health care, or insurance were reported. Findings add to the evidence suggesting the feasibility of phase I/II prophylactic HIV vaccine trials with low-risk volunteers in Thailand.

AB - Behavioral and social issues were investigated in phase I/II preventive HIV vaccine trial volunteers in Thailand. These included risk behavior, HIV knowledge, distress, and social experiences associated with trial participation. Data were collected at baseline and at 4- and 8-month follow- up visits. Volunteers reported relatively low levels of risk behaviors at baseline and at the follow-up visits. About one fifth reported overtly negative reactions from family or friends. No problems with discrimination in employment, health care, or insurance were reported. Findings add to the evidence suggesting the feasibility of phase I/II prophylactic HIV vaccine trials with low-risk volunteers in Thailand.

KW - Developing countries

KW - HIV sexual risk behavior

KW - HIV vaccine trials

KW - Thailand

UR - http://www.scopus.com/inward/record.url?scp=0032918879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032918879&partnerID=8YFLogxK

U2 - 10.1097/00042560-199903010-00015

DO - 10.1097/00042560-199903010-00015

M3 - Article

C2 - 10077182

AN - SCOPUS:0032918879

SN - 1077-9450

VL - 20

SP - 308

EP - 314

JO - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

JF - Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

IS - 3

ER -

Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this